Dalbavancin, vancomycin and daptomycin alone and in combination with cefazolin against resistant phenotypes of Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model

Jacinda C. Abdul-Mutakabbir; Razieh Kebriaei; Kyle C. Stamper; Zain Sheikh; Philip T. Maassen; Katherine L. Lev; Michael J. Rybak

doi:10.3390/antibiotics9100696

Dalbavancin, vancomycin and daptomycin alone and in combination with cefazolin against resistant phenotypes of Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model

Jacinda C. Abdul-Mutakabbir, Razieh Kebriaei, Kyle C. Stamper, Zain Sheikh, Philip T. Maassen, Katherine L. Lev, Michael J. Rybak

Microbiology Division

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	696
Pages (from-to)	1-12
Number of pages	12
Journal	Antibiotics
Volume	9
Issue number	10
DOIs	https://doi.org/10.3390/antibiotics9100696
State	Published - Oct 2020

ASJC Scopus Subject Areas

Microbiology
Biochemistry
General Pharmacology, Toxicology and Pharmaceutics
Microbiology (medical)
Infectious Diseases
Pharmacology (medical)

Keywords

Antimicrobial resistance
Pharmacodynamics
Pharmacokinetics
Staphylococcus aureus

Access to Document

10.3390/antibiotics9100696

OpenUrl availability

Full text

Cite this

Abdul-Mutakabbir, J. C., Kebriaei, R., Stamper, K. C., Sheikh, Z., Maassen, P. T., Lev, K. L., & Rybak, M. J. (2020). Dalbavancin, vancomycin and daptomycin alone and in combination with cefazolin against resistant phenotypes of Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model. Antibiotics, 9(10), 1-12. Article 696. https://doi.org/10.3390/antibiotics9100696

Dalbavancin, vancomycin and daptomycin alone and in combination with cefazolin against resistant phenotypes of Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model. / Abdul-Mutakabbir, Jacinda C.; Kebriaei, Razieh; Stamper, Kyle C. et al.
In: Antibiotics, Vol. 9, No. 10, 696, 10.2020, p. 1-12.

Research output: Contribution to journal › Article › peer-review

@article{b3205f94f34544d6abd500c8881f0917,

title = "Dalbavancin, vancomycin and daptomycin alone and in combination with cefazolin against resistant phenotypes of Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model",

keywords = "Antimicrobial resistance, Pharmacodynamics, Pharmacokinetics, Staphylococcus aureus",

author = "Abdul-Mutakabbir, \{Jacinda C.\} and Razieh Kebriaei and Stamper, \{Kyle C.\} and Zain Sheikh and Maassen, \{Philip T.\} and Lev, \{Katherine L.\} and Rybak, \{Michael J.\}",

note = "Publisher Copyright: {\textcopyright} 2020 by the authors.",

year = "2020",

month = oct,

doi = "10.3390/antibiotics9100696",

language = "English",

volume = "9",

pages = "1--12",

journal = "Antibiotics",

issn = "2079-6382",

number = "10",

}

TY - JOUR

T1 - Dalbavancin, vancomycin and daptomycin alone and in combination with cefazolin against resistant phenotypes of Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model

AU - Abdul-Mutakabbir, Jacinda C.

AU - Kebriaei, Razieh

AU - Stamper, Kyle C.

AU - Sheikh, Zain

AU - Maassen, Philip T.

AU - Lev, Katherine L.

AU - Rybak, Michael J.

PY - 2020/10

Y1 - 2020/10

KW - Antimicrobial resistance

KW - Pharmacodynamics

KW - Pharmacokinetics

KW - Staphylococcus aureus

UR - https://www.scopus.com/pages/publications/85092920610

UR - https://www.scopus.com/inward/citedby.url?scp=85092920610&partnerID=8YFLogxK

U2 - 10.3390/antibiotics9100696

DO - 10.3390/antibiotics9100696

M3 - Article

AN - SCOPUS:85092920610

SN - 2079-6382

VL - 9

SP - 1

EP - 12

JO - Antibiotics

JF - Antibiotics

IS - 10

M1 - 696

ER -

Dalbavancin, vancomycin and daptomycin alone and in combination with cefazolin against resistant phenotypes of Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this